Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children.
about
Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malariaeditDihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malariaDesigning the next generation of medicines for malaria control and eradicationNew developments in anti-malarial target candidate and product profilesDihydroartemisinin-piperaquine vs. artemether-lumefantrine for first-line treatment of uncomplicated malaria in African children: a cost-effectiveness analysisEfficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquineArtemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malariaDoes the Use of Dihydroartemisinin-Piperaquine in Treating Patients with Uncomplicated falciparum Malaria Reduce the Risk for Recurrent New falciparum Infection More Than Artemether-Lumefantrine?Longitudinal study on Plasmodium falciparum gametocyte carriage following artemether-lumefantrine administration in a cohort of children aged 12-47 months living in Western Kenya, a high transmission areaArtemisinin-based combination therapies are efficacious and safe for treatment of uncomplicated malaria in HIV-infected Ugandan childrenCost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania.Artemether-lumefantrine: an option for malaria.Malaria: an update on current chemotherapy.Therapeutic efficacy of artemether-lumefantrine on treatment of uncomplicated Plasmodium falciparum mono-infection in an area of high malaria transmission in Zambia.Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola.Comparative safety of artemether-lumefantrine and other artemisinin-based combinations in children: a systematic reviewRandomized non-inferiority and safety trial of dihydroartemisin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children.Development, evaluation, and application of an in silico model for antimalarial drug treatment and failure.Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and TanzaniaRandomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina FasoThe global pipeline of new medicines for the control and elimination of malariaTherapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest BeninIncreasing incidence of malaria in children despite insecticide-treated bed nets and prompt anti-malarial therapy in Tororo, UgandaThe effects of ACT treatment and TS prophylaxis on Plasmodium falciparum gametocytemia in a cohort of young Ugandan children.MMV in partnership: the Eurartesim® experience.A randomized trial of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated malaria among children in western KenyaImpact of intermittent screening and treatment for malaria among school children in Kenya: a cluster randomised trial.Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre studyEfficacy and safety of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in endemic countries: meta-analysis of randomised controlled studies.The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine.Coartem(®): a decade of patient-centric malaria management.Cochrane Column.Interactions between artemisinins and other antimalarial drugs in relation to the cofactor model--a unifying proposal for drug action.
P2860
Q21032449-6169E394-A067-49BE-80D5-0755F2B3FB51Q24201077-40EC77CE-2D5A-4B48-97EA-72F104DBFFB8Q26859195-3B32FC41-41A3-4EDE-8AC3-C44A31A2539BQ28468598-D01A9290-21A6-4C0A-A704-2F20AC399DFBQ28538065-0A5C20B0-A993-40C0-A056-8F62A2ACC6DEQ28542034-36ED0129-D731-41DD-B064-D64DE10058D2Q33696767-52B5A9DF-C85F-45AE-AB60-968D7140CA05Q33874069-6B284DF7-F0BC-469A-8961-AF413A5E0F4BQ33928116-311AC613-CF1F-42E1-A1D1-389FD4C1A100Q34137766-708950FD-6C15-4514-B9B8-C8DA5E0739BAQ34227179-1FCD2B64-DB6E-480D-B74E-D267DF8E3159Q34267667-78CEBBC5-C12F-42A3-B9C7-12984B1F0F2BQ34433106-AF3B2FDC-4E38-4367-BDB2-5A3A1B067A9BQ34894319-AF5D09B4-BE17-47A4-9336-57B0088CC3D4Q34922694-C5AEDB39-00FF-478C-8784-DBBEC42DAA3BQ35029488-EAEFD949-2A42-486B-93E6-884CA6461B2EQ35052961-00A25F72-3E26-496A-8E74-AE4CE6EC7EE6Q35065737-E3C44C6D-1E74-49CD-85A1-D5469DCDD0CEQ35519260-A61FDFDA-DD48-4569-84E3-8A96923E5F74Q35859844-B647DB7D-EB9F-4593-9783-A7C8E8962180Q36320249-8EBF5B99-F05C-4E01-B609-E33EA28A8B45Q36489791-19FC242B-2E2F-4166-8267-A48DFB93A3B5Q36552347-C1426E6C-AF98-46E8-927E-4912F725A713Q36743875-B1D4377F-BE14-49A1-864F-4D6B450067FBQ36952896-517BB9FA-EC28-40A4-8B04-789CAB97BA5FQ37042465-4DB92AB0-CBF5-4415-A0A8-52156F5810A7Q37524994-BDA6E241-1051-42FC-A9DA-ADAFDBB9D799Q37562847-282931B9-830F-4D23-ABE9-8C839D521B33Q38065917-164955E6-12B9-4EDD-8314-EE871288684BQ38529669-47E4F54C-F271-46DB-987D-23CA56313369Q39042892-68383017-F2AC-4216-9252-CB4FD8CC7B43Q39599642-F7487ED6-CA35-4F3E-9067-8D2A99F05625Q41927945-0937B310-7841-4DB4-AF5D-FB2405E44A34
P2860
Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Safety and efficacy of dihydro ...... m malaria in Zambian children.
@ast
Safety and efficacy of dihydro ...... m malaria in Zambian children.
@en
Safety and efficacy of dihydro ...... m malaria in Zambian children.
@nl
type
label
Safety and efficacy of dihydro ...... m malaria in Zambian children.
@ast
Safety and efficacy of dihydro ...... m malaria in Zambian children.
@en
Safety and efficacy of dihydro ...... m malaria in Zambian children.
@nl
prefLabel
Safety and efficacy of dihydro ...... m malaria in Zambian children.
@ast
Safety and efficacy of dihydro ...... m malaria in Zambian children.
@en
Safety and efficacy of dihydro ...... m malaria in Zambian children.
@nl
P2093
P2860
P921
P356
P1433
P1476
Safety and efficacy of dihydro ...... m malaria in Zambian children.
@en
P2093
David Ubben
Doreen Mukwamataba
Michael Nambozi
Mike Chaponda
Modest Mulenga
Sebastian Hachizovu
P2860
P2888
P356
10.1186/1475-2875-10-50
P577
2011-02-28T00:00:00Z
P5875
P6179
1035993080